Literature DB >> 6182771

A species comparison of the histamine H2-receptor on mast cells and basophils.

T J Rising, S Lewis.   

Abstract

The histamine H2-agonist dimaprit was employed in experiments to investigate the role of H2-receptors in mediator release systems from the rat, guinea-pig and man. Whereas inhibition of histamine release by dimaprit was observed in all 3 species, this effect appeared not always to be related to H2-receptor occupancy. Although the data in general support previous evidence for the presence of H2-receptors on human basophils and guinea-pig mast cells, the use of dimaprit as a pure H2-agonist in these studies is questioned. No evidence for H2-receptors on rat mast cells was obtained.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182771     DOI: 10.1007/bf01965386

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  27 in total

1.  THE MECHANISM OF ANAPHYLAXIS. I. PRODUCTION AND BIOLOGICAL PROPERTIES OF 'MAST CELL SENSITIZING' ANTIBODY.

Authors:  I MOTA
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

2.  Inhibition of the anaphylactic reaction.

Authors:  J L MONGAR; H O SCHILD
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

3.  Receptors mediating some actions of histamine.

Authors:  A S Ash; H O Schild
Journal:  Br J Pharmacol Chemother       Date:  1966-08

4.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

5.  Potentiated reagin response to egg albumin and conalbumin in Nippostrongylus brasiliensis infected rats.

Authors:  T S Orr; A M Blair
Journal:  Life Sci       Date:  1969-10-15       Impact factor: 5.037

6.  Brain histamine receptors as targets for antidepressant drugs.

Authors:  P D Kanof; P Greengard
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

7.  Effect of a histamine H-2-receptor antagonist on immunologically induced mediator release in vitro.

Authors:  L W Chakrin; R D Krell; J Mengel; D Young; C Zaher; J R Wardell
Journal:  Agents Actions       Date:  1974-12

8.  Human gastric mucosal adenylate cyclase: activation by histamine-H2-receptor stimulation and inhibition by cimetidine in vitro and in peptic ulcer patients.

Authors:  H J Ruoff; M Becker; B Painz; M Rack; K F Sewing; H Malchow
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

9.  The effects of H2-receptor antagonists on anaphylaxis in the guinea-pig.

Authors:  R Dulabh; M R Vickers
Journal:  Agents Actions       Date:  1978-12

10.  In vivo effect of cimetidine on canine pulmonary responsiveness to aerosol histamine.

Authors:  J R Snapper; P S Braasch; R H Ingram; S H Loring; J M Drazen
Journal:  J Allergy Clin Immunol       Date:  1980-07       Impact factor: 10.793

View more
  5 in total

1.  Pathophysiological significance of the distribution of histamine receptor sub-types: a proposed dual role for histamine in inflammation and type I hypersensitivity reactions.

Authors:  P F Mannaioni; R Fantozzi; E Giannella; E Masini
Journal:  Agents Actions       Date:  1988-06

2.  Surface histamine receptors in rat peritoneal mast cells. Separation of receptor-bearing cells via binding to a histamine-protein conjugate, Cell-ect.

Authors:  E Alm; G D Bloom; B A Fredriksson
Journal:  Agents Actions       Date:  1984-04

3.  A new in vivo method for the measurement of repetitive anaphylactic responses in the guinea-pig.

Authors:  K M Bottomley; S Lewis; T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

4.  The antianaphylactic action of histamine H2-receptor agonists in the guinea-pig isolated heart.

Authors:  P Blandina; S Brunelleschi; R Fantozzi; E Giannella; P F Mannaioni; E Masini
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

5.  Histamine receptors and COVID-19.

Authors:  Madeleine Ennis; Katerina Tiligada
Journal:  Inflamm Res       Date:  2020-11-18       Impact factor: 4.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.